Cargando…
Pharmacodynamic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with alcohol-use disorder
BACKGROUND: Antipsychotic action of haloperidol is due to blockade of D(2) receptors in the mesolimbic dopamine pathway, while the adverse drug reactions are associated with striatal D(2) receptor blockade. Contradictory data concerning the effects of genetic polymorphisms of genes encoding these re...
Autores principales: | Zastrozhin, Mikhail Sergeevich, Brodyansky, Vadim Markovich, Skryabin, Valentin Yurievich, Grishina, Elena Anatolievna, Ivashchenko, Dmitry Vladimirovich, Ryzhikova, Kristina Anatolievna, Savchenko, Ludmila Mikhaylovna, Kibitov, Alexander Olegovich, Bryun, Evgeny Alekseevich, Sychev, Dmitry Alekseevich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511016/ https://www.ncbi.nlm.nih.gov/pubmed/28744152 http://dx.doi.org/10.2147/PGPM.S140700 |
Ejemplares similares
-
The influence of CYP3A5 polymorphisms on haloperidol treatment in patients with alcohol addiction
por: Zastrozhin, Mikhail Sergeevich, et al.
Publicado: (2017) -
The correlation between CYP2D6 isoenzyme activity and haloperidol efficacy and safety profile in patients with alcohol addiction during the exacerbation of the addiction
por: Sychev, Dmitry Alekseevich, et al.
Publicado: (2016) -
Effects of CYP2D6 genetic polymorphisms on the efficacy and safety of fluvoxamine in patients with depressive disorder and comorbid alcohol use disorder
por: Zastrozhin, Mikhail Sergeevich, et al.
Publicado: (2018) -
Influence of ABCB1 and CYP3A5 gene polymorphisms on pharmacokinetics of apixaban in patients with atrial fibrillation and acute stroke
por: Kryukov, Alexander Valerevich, et al.
Publicado: (2018) -
A case of olanzapine-associated rhabdomyolysis
por: Skryabin, Valentin, et al.
Publicado: (2021)